AIP
TMDX icon

Arrowpoint Investment Partners’s Transmedics TMDX Stock Holding History

Arrowpoint Investment Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,800
Closed -$112K – 1229
2024
Q4 		$112K Buy
+1,800
New +$168K 0.02% 565

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowpoint Investment Partners's TMDX Position: Q1 2025 in Review

Arrowpoint Investment Partners sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 1,650 shares — an estimated $103K sold.

Arrowpoint Investment Partners first reported a position in TMDX in Q4 2024 and held it in 1 quarter. The position peaked at $103K in Q4 2024. 299 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Arrowpoint Investment Partners reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 1,650 Transmedics shares in Q1 2025, an estimated $103K.
  • Arrowpoint Investment Partners first reported a position in Transmedics in Q4 2024 and held it in 1 quarter.
  • Arrowpoint Investment Partners's Transmedics position peaked at $103K in Q4 2024.
  • 299 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.